Dermatite atópica e filagrina: restaurando barreiras para o controle da doença
Atopic dermatitis and filaggrin: restoring barriers to control the disease
Renata N. Cardili; Janaina M. L. Melo; Ana M. Roselino; Adriana S. Moreno; Ana Paula M. Castro; L. Karla Arruda
Referências
1. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483-94.
2. Solé D, Mallol J, Wandalsen GF, Aguirre V; Latin American ISAAC Phase 3 Study Group. Prevalence of symptoms of eczema in Latin America: results of the International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3. J Investig Allergol Clin Immunol. 2010;20(4):311-23.
3. Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365(14):1315‑27.
4. Agrawal R, Woodfolk JA. Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep. 2014;14(5):433.
5. Czarnowicki T, Krueger JG, Guttman-Yassky E. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications. J Allergy Clin Immunol Pract. 2014;2(4):371-9.
6. Eyerich K, Novak N. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy. 2013;68(8):974-82.
7. Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130-9.
8. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med. 2013;368(26):2455-66.
9. Mohiuddin MS, Ramamoorthy P, Reynolds PR, Curran-Everett D, Leung DY. Increased compound heterozygous filaggrin mutations in severe atopic dermatitis in the United States. J Allergy Clin Immunol Pract. 2013;1(5):534-6.
10. Muehleisen B1, Gallo RL. Vitamin D in allergic disease: shedding light on a complex problem. J Allergy Clin Immunol. 2013;131(2):324-9.
11. Robl R, Carvalho VO, Uber M, Abagge KT, Pereira RM. Vitamina D e dermatite atópica: o que há de novo? Braz J Allergy Immunol. 2013;1(5):261-6.
12. Stout TE, McFarland T, Mitchell JC, Appukuttan B, Stout JT. Recombinant filaggrin is internalized and processed to correct filaggrin deficiency. J Invest Dermatol. 2014;134(2):423-9.
13. McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131:280-91.
Facebook
LinkedIn
Mendeley
StumbleUpon
Reddit
Email